CVS Health Corporation Announces Q1 2025 Financial Results

CVS Health Corporation has reported a 7% annual increase in revenue for the first quarter of 2025, reaching $94.6 billion. Despite this growth, the figures fell short of market expectations. The company's net income stood at $1.78 billion, a significant rise from $1.12 billion in the same period last year. Diluted earnings per share (EPS) also saw an improvement, hitting $1.41 compared to $0.88 in 2024.

Revised Financial Guidance for 2025

In light of these results, CVS Health has adjusted its full-year 2025 cash flow from operations guidance downward by $500 million to $7.0 billion. The GAAP diluted EPS guidance is now expected to range between $4.23 and $4.43.

Leadership Comments and Market Reaction

"Our dedicated team at CVS Health has achieved positive outcomes across all segments, including Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness, as we strive to enhance health care for the 185 million consumers we serve," stated President and CEO David Joyner. Following the announcement, CVS shares experienced a 4.79% increase in premarket trading, reaching $71.5 per share.